Stéphane Sarrazin

580 total citations
17 papers, 487 citations indexed

About

Stéphane Sarrazin is a scholar working on Molecular Biology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Stéphane Sarrazin has authored 17 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cell Biology and 5 papers in Organic Chemistry. Recurrent topics in Stéphane Sarrazin's work include Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Inflammation biomarkers and pathways (5 papers). Stéphane Sarrazin is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Inflammation biomarkers and pathways (5 papers). Stéphane Sarrazin collaborates with scholars based in France, United States and Germany. Stéphane Sarrazin's co-authors include Hugues Lortat‐Jacob, David Bonnaffé, André Lubineau, Jeffrey D. Esko, Maryse Delehedde, William C. Lamanna, Roger Lawrence, Yitzhak Tor, Philippe Lassalle and Estelle Adam and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Stéphane Sarrazin

17 papers receiving 479 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Sarrazin France 12 212 171 120 104 74 17 487
Bhairavi N. Vajaria India 8 377 1.8× 65 0.4× 164 1.4× 61 0.6× 74 1.0× 11 563
Yen‐Hsi Chen Denmark 11 334 1.6× 139 0.8× 112 0.9× 101 1.0× 29 0.4× 16 539
Karin E. Norgard-Sumnicht United States 7 417 2.0× 346 2.0× 130 1.1× 100 1.0× 17 0.2× 7 791
Jin-Ping Li Sweden 10 376 1.8× 389 2.3× 36 0.3× 87 0.8× 16 0.2× 15 571
Yiling Mi United States 9 267 1.3× 50 0.3× 114 0.9× 55 0.5× 18 0.2× 14 387
Nobuto Koyama Japan 11 334 1.6× 41 0.2× 166 1.4× 65 0.6× 12 0.2× 14 516
Irene Ivhed Sweden 9 287 1.4× 70 0.4× 177 1.5× 30 0.3× 27 0.4× 12 556
James L. Mobley United States 12 152 0.7× 27 0.2× 246 2.0× 35 0.3× 46 0.6× 18 504
K Hochstrasser Germany 11 201 0.9× 53 0.3× 59 0.5× 31 0.3× 74 1.0× 71 529
Erik Corcoran United States 9 215 1.0× 46 0.3× 44 0.4× 42 0.4× 7 0.1× 12 481

Countries citing papers authored by Stéphane Sarrazin

Since Specialization
Citations

This map shows the geographic impact of Stéphane Sarrazin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Sarrazin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Sarrazin more than expected).

Fields of papers citing papers by Stéphane Sarrazin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Sarrazin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Sarrazin. The network helps show where Stéphane Sarrazin may publish in the future.

Co-authorship network of co-authors of Stéphane Sarrazin

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Sarrazin. A scholar is included among the top collaborators of Stéphane Sarrazin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Sarrazin. Stéphane Sarrazin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lamanna, William C., Chrissa A. Dwyer, Daniel R. Sandoval, et al.. (2022). Impaired mitophagy in Sanfilippo a mice causes hypertriglyceridemia and brown adipose tissue activation. Journal of Biological Chemistry. 298(8). 102159–102159. 3 indexed citations
2.
Dwyer, Chrissa A., Bryan E. Thacker, Charles A. Glass, et al.. (2017). Guanidinylated Neomycin Conjugation Enhances Intranasal Enzyme Replacement in the Brain. Molecular Therapy. 25(12). 2743–2752. 11 indexed citations
3.
Badillo, Aurélie, Véronique Receveur‐Brechot, Stéphane Sarrazin, et al.. (2017). Overall Structural Model of NS5A Protein from Hepatitis C Virus and Modulation by Mutations Confering Resistance of Virus Replication to Cyclosporin A. Biochemistry. 56(24). 3029–3048. 23 indexed citations
4.
Lavie, Muriel, Stéphane Sarrazin, Roland Montserret, et al.. (2014). Identification of Conserved Residues in Hepatitis C Virus Envelope Glycoprotein E2 That Modulate Virus Dependence on CD81 and SRB1 Entry Factors. Journal of Virology. 88(18). 10584–10597. 30 indexed citations
5.
Sarrazin, Stéphane, Cédric Laguri, Rabia Sadir, et al.. (2013). Insights into the Mechanism by Which Interferon-γ Basic Amino Acid Clusters Mediate Protein Binding to Heparan Sulfate. Journal of the American Chemical Society. 135(25). 9384–9390. 38 indexed citations
6.
Lamanna, William C., Roger Lawrence, Stéphane Sarrazin, et al.. (2012). A Genetic Model of Substrate Reduction Therapy for Mucopolysaccharidosis. Journal of Biological Chemistry. 287(43). 36283–36290. 22 indexed citations
7.
Sarrazin, Stéphane, et al.. (2010). Cooperative, Heparan Sulfate‐Dependent Cellular Uptake of Dimeric Guanidinoglycosides. ChemBioChem. 11(16). 2302–2310. 28 indexed citations
8.
Lamanna, William C., Roger Lawrence, Stéphane Sarrazin, & Jeffrey D. Esko. (2010). Secondary Storage of Dermatan Sulfate in Sanfilippo Disease. Journal of Biological Chemistry. 286(9). 6955–6962. 45 indexed citations
9.
Sarrazin, Stéphane, et al.. (2010). Guanidinylated Neomycin Mediates Heparan Sulfate–dependent Transport of Active Enzymes to Lysosomes. Molecular Therapy. 18(7). 1268–1274. 27 indexed citations
10.
Gendrin, Claire, Stéphane Sarrazin, David Bonnaffé, et al.. (2010). Hijacking of the Pleiotropic Cytokine Interferon-γ by the Type III Secretion System of Yersinia pestis. PLoS ONE. 5(12). e15242–e15242. 5 indexed citations
11.
Sarrazin, Stéphane, et al.. (2010). Endocan as a Biomarker of Endothelial Dysfunction in Cancer. Journal of Cancer Science & Therapy. 2(2). 47–52. 25 indexed citations
12.
Caires, Nathalie De Freitas, Stéphane Sarrazin, Florence Depontieu, et al.. (2010). Identification Of Cathepsin G In The Generation Of Elastase-resistant Fragment Of The Vascular Endocan. Involvement In The Regulation Of LFA-1-dependent Cascade. A6475–A6475. 1 indexed citations
13.
Maurage, Claude‐Alain, Estelle Adam, Jean-François Minéo, et al.. (2009). Endocan Expression and Localization in Human Glioblastomas. Journal of Neuropathology & Experimental Neurology. 68(6). 633–641. 93 indexed citations
14.
Adam, Estelle, et al.. (2008). Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor. Biochemical and Biophysical Research Communications. 369(2). 297–302. 8 indexed citations
15.
Sarrazin, Stéphane, David Bonnaffé, André Lubineau, & Hugues Lortat‐Jacob. (2005). Heparan Sulfate Mimicry. Journal of Biological Chemistry. 280(45). 37558–37564. 48 indexed citations
16.
Lubineau, André, et al.. (2004). Synthesis of Tailor‐Made Glycoconjugate Mimetics of Heparan Sulfate That Bind IFN‐γ in the Nanomolar Range. Chemistry - A European Journal. 10(17). 4265–4282. 79 indexed citations
17.
Sarrazin, Stéphane, David Béchard, Philippe Lassalle, et al.. (2004). Purification and characterization of endocan (endothelial cell‐specific molecule‐1), a circulating proteoglycan involved in tumour progression and inflammatory diseases. International Journal of Experimental Pathology. 85(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bhairavi N. Vajaria Breakdown of academic impact, for papers by Yen‐Hsi Chen Breakdown of academic impact, for papers by Karin E. Norgard-Sumnicht Breakdown of academic impact, for papers by Jin-Ping Li Breakdown of academic impact, for papers by Yiling Mi Breakdown of academic impact, for papers by Nobuto Koyama Breakdown of academic impact, for papers by Irene Ivhed Breakdown of academic impact, for papers by James L. Mobley Breakdown of academic impact, for papers by K Hochstrasser Breakdown of academic impact, for papers by Erik Corcoran
Rankless by CCL
2026